Valentina Perrone
Overview
Explore the profile of Valentina Perrone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perrone V, Leogrande M, Cappuccilli M, Saragoni S, Cinti Luciani A, Degli Esposti L
Clinicoecon Outcomes Res
. 2025 Mar;
17:147-155.
PMID: 40066280
Purpose: To describe patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer (HR+/HER2- mBC) in Italy for demographic and clinical variables, comorbidity profile,...
2.
Perrone V, Usala M, Veronesi C, Cappuccilli M, Degli Esposti L
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005338
: This analysis described rifaximin utilization in Italian patients with hepatic encephalopathy (HE). Although rifaximin is effective in preventing HE relapses, therapeutic management and prescriptive attitudes might be improved. :...
3.
Perrone V, Leogrande M, Cappuccilli M, Degli Esposti L
Blood Res
. 2024 Oct;
59(1):30.
PMID: 39377876
Purpose: This real-world analysis described the Hemophilia A (HA) population in Italy, evaluating drug utilization and consumption of factor VIII (FVIII) products of patients under prophylaxis and on-demand therapy. Methods:...
4.
Perrone V, Medea G, Urbinati S, Sangiorgi D, Degli Esposti L
Glob Reg Health Technol Assess
. 2024 Jun;
11:138-147.
PMID: 38872910
No abstract available.
5.
Perrone V, Silvia Sabatino , Avitabile A, Dovizio M, Leogrande M, Degli Esposti L
Ital J Dermatol Venerol
. 2024 Apr;
159(2):182-189.
PMID: 38650498
Background: This real-world analysis aimed at characterizing patients hospitalized for alopecia areata (AA) in Italy, focusing on comorbidities, treatment patterns and the economic burden for disease management. Methods: Administrative databases...
6.
Dovizio M, Hartz S, Buzzoni C, Redondo I, Nedeljkovic Protic M, Birra D, et al.
Adv Ther
. 2024 Apr;
41(6):2282-2298.
PMID: 38619721
Introduction: Real-world data are used to inform decision-makers and optimise therapeutic management for patients with ulcerative colitis (UC) and Crohn's disease (CD). We analysed data on the epidemiology (by using...
7.
Dovizio M, Veronesi C, Bartolini F, Cavaliere A, Grego S, Pagliaro R, et al.
Ital J Pediatr
. 2024 Mar;
50(1):57.
PMID: 38528616
Background: Respiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in children younger than 5 years worldwide and the second cause...
8.
Bo M, Fumagalli S, Degli Esposti L, Perrone V, Dovizio M, Poli D, et al.
Eur J Intern Med
. 2023 Oct;
121:88-94.
PMID: 37879969
Introduction: In a large nationwide administrative database including ∼35 % of Italian population, we analyzed the impact of oral anticoagulant treatment (OAT) in patients with a hospital diagnosis of non-valvular...
9.
Degli Esposti L, Dovizio M, Perrone V, Veronesi C, Andretta M, Bacca M, et al.
Adv Ther
. 2023 Oct;
40(12):5338-5353.
PMID: 37787877
Introduction: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are rare autoimmune diseases triggering inflammation of small vessels. This real-world analysis was focused on the most common AAV forms, granulomatosis with polyangiitis...
10.
Degli Esposti L, Perrone V, Dovizio M, Sangiorgi D, Di Cesare A, Rosi E, et al.
Ital J Dermatol Venerol
. 2023 Sep;
158(6):445-451.
PMID: 37768706
Background: Psoriasis (PSO) patients can benefit from the growing availability of novel biological agents, that are often underused or discontinued. This real-world analysis estimated PSO patients potentially eligible and currently...